Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
352K
-
Shares change
-
-59.2M
-
Total reported value, excl. options
-
$1.32M
-
Value change
-
-$55.3M
-
Number of sells
-
-85
-
Price
-
$3.74
Significant Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q1 2025
91 filings reported holding KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 352K shares
of 126M outstanding shares and own 0.28% of the company stock.
Largest 10 shareholders include Palo Alto Investors LP (324K shares), Birchview Capital, LP (28K shares), West Branch Capital LLC (0 shares), Janney Montgomery Scott LLC (0 shares), KENNEDY INVESTMENT GROUP (0 shares), BLB&B Advisors, LLC (0 shares), Allworth Financial LP (0 shares), Bank of New York Mellon Corp (0 shares), ELCO Management Co., LLC (0 shares), and EXCHANGE TRADED CONCEPTS, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.